111 related articles for article (PubMed ID: 77224)
21. Cell-mediated immune reactions as probes of sensitization to tumour-associated antigens of methylcholanthrene-induced mouse sarcomas.
Bubeník J; Indrová M; Malkovský M; Símová J
Arch Geschwulstforsch; 1981; 51(4):349-53. PubMed ID: 6172086
[TBL] [Abstract][Full Text] [Related]
22. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
Lampert F; Nitzschke U; Zwergel T
Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
[TBL] [Abstract][Full Text] [Related]
23. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.
Braun DP; Dray S
Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048
[TBL] [Abstract][Full Text] [Related]
24. Demonstration of tumor-associated immunity with a leukocyte adherence inhibition (LAI) assay.
Hellström I; Hellström KE; Shantz G
Int J Cancer; 1976 Sep; 18(3):354-61. PubMed ID: 955746
[TBL] [Abstract][Full Text] [Related]
25. [Cross-reactivity of 3M KCl extracts of fetal tissue from various species in the macrophage electrophoresis mobility (MEM) test. I. Extracts from fetuses of mammals and one species of fowl].
Schlott B; Gryschek G; Reinhöfer J; von Broen B; Pasternak G
Arch Geschwulstforsch; 1983; 53(2):93-8. PubMed ID: 6344836
[TBL] [Abstract][Full Text] [Related]
26. Cellular immunity to bovine myelin basic protein in rats bearing malignant fibrous histiocytoma.
Ribeiro RA; Lopes-Alberto F; De-Lucca FL
Braz J Med Biol Res; 1989; 22(6):721-4. PubMed ID: 2482789
[TBL] [Abstract][Full Text] [Related]
27. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Hoffmann W; Werner W; Steiner R; Kaufmann R
Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
[TBL] [Abstract][Full Text] [Related]
28. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. II. Tumor transplantation studies.
Ting CC; Rodrigues D; Herberman RB
Int J Cancer; 1973 Sep; 12(2):519-23. PubMed ID: 4134567
[No Abstract] [Full Text] [Related]
29. Cross-reactions among mouse tumors of different etiology as detected by macrophage electrophoretic mobility (MEM) test.
Pasternak L; Jenssen HL; Köhler H; Pasternak G
Eur J Cancer (1965); 1976 May; 12(5):389-93. PubMed ID: 954796
[No Abstract] [Full Text] [Related]
30. Demonstration of cross-reacting tumor rejection antigens in chemically induced respiratory tract carcinomas in rats.
Jamasbi RJ; Nettesheim P
Cancer Res; 1977 Nov; 37(11):4059-63. PubMed ID: 71203
[TBL] [Abstract][Full Text] [Related]
31. Common tumor-associated transplantation alloantigen detected on a proportion of lung tumors induced transplacentally in several strains of mice.
Martin WJ; Gipson TG; Conliffe M; Friedman R; Dove L; Rice JM
Transplantation; 1977 Oct; 24(4):294-6. PubMed ID: 919025
[No Abstract] [Full Text] [Related]
32. New preclinical models for testing antitumor drugs. The immuno-chemotherapy index.
Frati L; Riccardi C; Bartocci A; Bonmassar E
Arch Geschwulstforsch; 1978; 48(7):660-4. PubMed ID: 736747
[No Abstract] [Full Text] [Related]
33. Protection of mice against syngeneic C1300 neuroblastoma challenge by immunization with membranes of C1300 neuroblastoma cells.
Lauro G; Businaro R; Butler RH; Revoltella R
J Natl Cancer Inst; 1980 May; 64(5):1169-72. PubMed ID: 6929017
[TBL] [Abstract][Full Text] [Related]
34. Reactivity in neoplasia, preneoplasia, and pregnancy of lymphocytes against fetal extracts: cross-reactions between man and mouse.
Pasternak G; Schlott B; Reinhöfer J; Gryschek G; von Broen B; Albrecht S
J Natl Cancer Inst; 1982 Nov; 69(5):997-1004. PubMed ID: 6957663
[TBL] [Abstract][Full Text] [Related]
35. Some biologic and biochemical properties of soluble tumor antigens.
Law LW; Appella E; Henriksen O; Rogers M
Ann N Y Acad Sci; 1976; 276():11-25. PubMed ID: 194514
[No Abstract] [Full Text] [Related]
36. Host response to tumor-associated fetal antigens: kinetics and components.
Salinas FA
J Natl Cancer Inst; 1976 Aug; 57(2):349-54. PubMed ID: 63559
[TBL] [Abstract][Full Text] [Related]
37. Modification of the anti-tumour immune response by suppressor gene products of lymphoid cells.
De Giorgi L; Matossian-Rogers A; Festenstein H
Immunology; 1979 Apr; 36(4):711-8. PubMed ID: 108205
[TBL] [Abstract][Full Text] [Related]
38. Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay.
Economou GC; Takelchi N; Boone CW
Cancer Res; 1977 Jan; 37(1):37-41. PubMed ID: 63329
[TBL] [Abstract][Full Text] [Related]
39. Spleen-cell reactivity against transplanted neurogenic rat tumors induced by ethylnitrosourea: uncovering of tumor specificity after removal of complement-receptor-bearing lymphocytes.
Cornain S; Carnaud C; Silverman D; Klein E; Rajewsky MF
Int J Cancer; 1975 Aug; 16(2):301-11. PubMed ID: 50296
[TBL] [Abstract][Full Text] [Related]
40. Tumor delayed hypersensitivity reactions. "In vivo" functional differences between spleen and peripheral blood lymphocytes.
de Bonaparte YP; Oisgold-Dagá S; Klein S; Stillitani-D'Elia I
Biomedicine; 1980 Feb; 33(1):16-8. PubMed ID: 7370382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
